Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial

Louise Maes; Claudia Verschuere; Cathal Walsh; Christian Weimar; Francisco Purroy; Christopher Price; Catarina Fonseca; Michael D. Hill; Dalius Jatuzis; Janika Kõrv; Christina Kruuse; Robert Mikulik; Paul Nederkoorn; Anna Czlonkowska; Urs Fischer; Michael McCormick; Maria Castellanos; Miguel Baptista; João Pedro Marto; Kamy Thavanesan; David J. Williams; Peter Kelly; Robin Lemmens

doi:10.1093/esj/aakag033

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial

Louise Maes
, Claudia Verschuere
, Cathal Walsh
, Christian Weimar
, Francisco Purroy
, Christopher Price
, Catarina Fonseca
, Michael D. Hill
, Dalius Jatuzis
, Janika Kõrv
, Christina Kruuse
, Robert Mikulik
, Paul Nederkoorn
, Anna Czlonkowska
, Urs Fischer
, Michael McCormick
, Maria Castellanos
, Miguel Baptista
, João Pedro Marto
, Kamy Thavanesan

David J. Williams, Peter Kelly, Robin Lemmens

KU Leuven
Trinity College Dublin
BDH-Clinic Elzach
University of Duisburg-Essen
Hospitalt Universitari Arnau de Vilanova de Lleida
IRBLleida
Newcastle University
University of Lisbon
University of Calgary
Vilnius University
University of Tartu
University of Copenhagen
Masaryk University
Amsterdam UMC - University of Amsterdam
Institute of Psychiatry and Neurology, Warszawa
University of Bern
Southern Health and Social Care Trust
University of A Coruna
ULS Lisboa Ocidental
NOVA University Lisbon
University Hospitals Dorset NHS Foundation Trust
University College Dublin
Royal College of Surgeons in Ireland

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Stroke Journal
Volume	11
Issue number	4
DOIs	https://doi.org/10.1093/esj/aakag033
Publication status	Published - Apr 2026
Externally published	Yes

Keywords

atherosclerotic cardiovascular disease
colchicine
risk estimation
risk factors
secondary prevention
stroke
transient ischaemic attack

Access to Document

10.1093/esj/aakag033

Cite this

Maes, L., Verschuere, C., Walsh, C., Weimar, C., Purroy, F., Price, C., Fonseca, C., Hill, M. D., Jatuzis, D., Kõrv, J., Kruuse, C., Mikulik, R., Nederkoorn, P., Czlonkowska, A., Fischer, U., McCormick, M., Castellanos, M., Baptista, M., Marto, J. P., ... Lemmens, R. (2026). Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial. European Stroke Journal, 11(4). https://doi.org/10.1093/esj/aakag033

@article{273b37e11e654b2f823d578f6321100a,

title = "Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial",

keywords = "atherosclerotic cardiovascular disease, colchicine, risk estimation, risk factors, secondary prevention, stroke, transient ischaemic attack",

author = "Louise Maes and Claudia Verschuere and Cathal Walsh and Christian Weimar and Francisco Purroy and Christopher Price and Catarina Fonseca and Hill, \{Michael D.\} and Dalius Jatuzis and Janika K{\~o}rv and Christina Kruuse and Robert Mikulik and Paul Nederkoorn and Anna Czlonkowska and Urs Fischer and Michael McCormick and Maria Castellanos and Miguel Baptista and Marto, \{Jo{\~a}o Pedro\} and Kamy Thavanesan and Williams, \{David J.\} and Peter Kelly and Robin Lemmens",

year = "2026",

month = apr,

doi = "10.1093/esj/aakag033",

language = "English",

volume = "11",

journal = "European Stroke Journal",

issn = "2396-9873",

number = "4",

}

Maes, L, Verschuere, C, Walsh, C, Weimar, C, Purroy, F, Price, C, Fonseca, C, Hill, MD, Jatuzis, D, Kõrv, J, Kruuse, C, Mikulik, R, Nederkoorn, P, Czlonkowska, A, Fischer, U, McCormick, M, Castellanos, M, Baptista, M, Marto, JP, Thavanesan, K, Williams, DJ, Kelly, P & Lemmens, R 2026, 'Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial', European Stroke Journal, vol. 11, no. 4. https://doi.org/10.1093/esj/aakag033

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial. / Maes, Louise; Verschuere, Claudia; Walsh, Cathal et al.
In: European Stroke Journal, Vol. 11, No. 4, 04.2026.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category

T2 - a secondary analysis of the CONVINCE randomised clinical trial

AU - Maes, Louise

AU - Verschuere, Claudia

AU - Walsh, Cathal

AU - Weimar, Christian

AU - Purroy, Francisco

AU - Price, Christopher

AU - Fonseca, Catarina

AU - Hill, Michael D.

AU - Jatuzis, Dalius

AU - Kõrv, Janika

AU - Kruuse, Christina

AU - Mikulik, Robert

AU - Nederkoorn, Paul

AU - Czlonkowska, Anna

AU - Fischer, Urs

AU - McCormick, Michael

AU - Castellanos, Maria

AU - Baptista, Miguel

AU - Marto, João Pedro

AU - Thavanesan, Kamy

AU - Williams, David J.

AU - Kelly, Peter

AU - Lemmens, Robin

PY - 2026/4

Y1 - 2026/4

KW - atherosclerotic cardiovascular disease

KW - colchicine

KW - risk estimation

KW - risk factors

KW - secondary prevention

KW - stroke

KW - transient ischaemic attack

UR - https://www.scopus.com/pages/publications/105036905733

U2 - 10.1093/esj/aakag033

DO - 10.1093/esj/aakag033

M3 - Article

C2 - 42032972

AN - SCOPUS:105036905733

SN - 2396-9873

VL - 11

JO - European Stroke Journal

JF - European Stroke Journal

IS - 4

ER -

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial

Keywords

Access to Document

Other files and links

Cite this